生存率-话题@MedSci

#生存率#

482篇内容 | 3056人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256785, encodeId=14441256e85ce, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2020中国肺癌防治高峰论坛在京召开，多方助力提高肺癌5年生存率, objectType=article, longId=200672, objectId=b12f2006e20d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b12f2006e20d, replyNumber=0, likeNumber=46, createdTime=2020-09-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b12f2006e20d, moduleTitle=2020中国肺癌防治高峰论坛在京召开，多方助力提高肺癌5年生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b12f2006e20d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256784, encodeId=4fef1256e8491, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=三阴性乳腺癌：令人闻风丧胆的肿瘤！3种新疗法或将提高生存率, objectType=article, longId=200565, objectId=d66d2005656f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d66d2005656f, replyNumber=0, likeNumber=73, createdTime=2020-09-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d66d2005656f, moduleTitle=三阴性乳腺癌：令人闻风丧胆的肿瘤！3种新疗法或将提高生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d66d2005656f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256783, encodeId=f9771256e83d7, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA：皮质类固醇可提高COVID-19患者的生存率, objectType=article, longId=200360, objectId=7d1420036087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d1420036087, replyNumber=0, likeNumber=74, createdTime=2020-09-08, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d1420036087, moduleTitle=JAMA：皮质类固醇可提高COVID-19患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d1420036087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256782, encodeId=ca981256e825d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J INTERN MED：痴呆患者服用钙通道阻滞剂与生存率和缺血性卒中之间的关系, objectType=article, longId=200034, objectId=58c820003453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c820003453, replyNumber=0, likeNumber=126, createdTime=2020-08-31, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c820003453, moduleTitle=J INTERN MED：痴呆患者服用钙通道阻滞剂与生存率和缺血性卒中之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c820003453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256781, encodeId=2b821256e8106, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Oncol：三阴性乳腺癌治疗再添“白金方案”，五年无病生存率达86.5%, objectType=article, longId=199937, objectId=34c119993eb9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34c119993eb9, replyNumber=0, likeNumber=82, createdTime=2020-08-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34c119993eb9, moduleTitle=JAMA Oncol：三阴性乳腺癌治疗再添“白金方案”，五年无病生存率达86.5%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34c119993eb9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256780, encodeId=dbc41256e807b, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=EuroIntervention：肥胖悖论——BMI的适度增加与PCI后患者生存率的改善相关, objectType=article, longId=199792, objectId=bca6199e92da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bca6199e92da, replyNumber=0, likeNumber=99, createdTime=2020-08-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bca6199e92da, moduleTitle=EuroIntervention：肥胖悖论——BMI的适度增加与PCI后患者生存率的改善相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bca6199e92da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256779, encodeId=35401256e7908, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Oncol ：“最毒”乳腺癌生存率提高！精准辅助治疗“复旦方案”登上《美国医学会杂志-肿瘤学》, objectType=article, longId=199513, objectId=d21019951334, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21019951334, replyNumber=0, likeNumber=75, createdTime=2020-08-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21019951334, moduleTitle=JAMA Oncol ：“最毒”乳腺癌生存率提高！精准辅助治疗“复旦方案”登上《美国医学会杂志-肿瘤学》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d21019951334)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256778, encodeId=50ab1256e788a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet Oncol ：不同治疗和影像检查对癌症生存率影响多大？哈佛团队分析200国11种癌症数据, objectType=article, longId=199370, objectId=f6771993e0fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6771993e0fe, replyNumber=0, likeNumber=70, createdTime=2020-08-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6771993e0fe, moduleTitle=Lancet Oncol ：不同治疗和影像检查对癌症生存率影响多大？哈佛团队分析200国11种癌症数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6771993e0fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256777, encodeId=eb5f1256e7715, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Hepatology：25-羟维生素D的血清的生物利用度而不是总水平与肝细胞癌的生存率有关, objectType=article, longId=199285, objectId=c4dd1992857b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4dd1992857b, replyNumber=0, likeNumber=71, createdTime=2020-08-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4dd1992857b, moduleTitle=Hepatology：25-羟维生素D的血清的生物利用度而不是总水平与肝细胞癌的生存率有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4dd1992857b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256776, encodeId=9c261256e768f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAHA：扩张型心肌病患儿心率升高与生存率的关系, objectType=article, longId=198421, objectId=bee7198421f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bee7198421f9, replyNumber=0, likeNumber=61, createdTime=2020-08-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bee7198421f9, moduleTitle=JAHA：扩张型心肌病患儿心率升高与生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee7198421f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256775, encodeId=c3731256e758d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NEJM：结肠癌化疗时间减半不影响患者生存率，还可显著降低副作用！, objectType=article, longId=197904, objectId=6c4b19e904fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c4b19e904fa, replyNumber=0, likeNumber=143, createdTime=2020-07-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c4b19e904fa, moduleTitle=NEJM：结肠癌化疗时间减半不影响患者生存率，还可显著降低副作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c4b19e904fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256774, encodeId=1c9e1256e74de, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=GUT: COVID-19病毒对肝硬化患者生存率的影响, objectType=article, longId=197717, objectId=591719e71703, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=591719e71703, replyNumber=0, likeNumber=79, createdTime=2020-07-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=591719e71703, moduleTitle=GUT: COVID-19病毒对肝硬化患者生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=591719e71703)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256773, encodeId=74141256e73b3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Hepatology：丙型肝炎相关肝细胞癌患者使用无干扰素直接作用抗病毒药物可以提高生存率, objectType=article, longId=197273, objectId=04cd19e273d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04cd19e273d9, replyNumber=0, likeNumber=108, createdTime=2020-07-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04cd19e273d9, moduleTitle=Hepatology：丙型肝炎相关肝细胞癌患者使用无干扰素直接作用抗病毒药物可以提高生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04cd19e273d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256772, encodeId=943a1256e72ee, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AACR 2020：PD-L1单抗Tecentriq联合卡铂和依托泊苷，可提高小细胞肺癌SCLC生存率, objectType=article, longId=196545, objectId=5a8619654517, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a8619654517, replyNumber=0, likeNumber=49, createdTime=2020-06-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a8619654517, moduleTitle=AACR 2020：PD-L1单抗Tecentriq联合卡铂和依托泊苷，可提高小细胞肺癌SCLC生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a8619654517)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256771, encodeId=6aee1256e71b3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Thorax：家庭可支配收入与肺癌切除术后的长期生存率, objectType=article, longId=196226, objectId=f8a419622632, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8a419622632, replyNumber=0, likeNumber=48, createdTime=2020-06-23, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8a419622632, moduleTitle=Thorax：家庭可支配收入与肺癌切除术后的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8a419622632)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256770, encodeId=2dc91256e70ad, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO 2020丨遗憾！早期局部治疗未能改善原发IV期乳腺癌女性的总生存率, objectType=article, longId=195299, objectId=c885195299eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c885195299eb, replyNumber=0, likeNumber=59, createdTime=2020-06-06, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c885195299eb, moduleTitle=ASCO 2020丨遗憾！早期局部治疗未能改善原发IV期乳腺癌女性的总生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c885195299eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256769, encodeId=25951256e69cd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Gut：高收入国家的结肠癌和直肠癌生存率, objectType=article, longId=195181, objectId=5d061951816a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d061951816a, replyNumber=0, likeNumber=85, createdTime=2020-06-04, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d061951816a, moduleTitle=Gut：高收入国家的结肠癌和直肠癌生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d061951816a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256768, encodeId=04211256e68a6, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Hepatology：研究发现新的机制或可提高肝细胞癌患者的生存率, objectType=article, longId=194807, objectId=8a7519480ec3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a7519480ec3, replyNumber=0, likeNumber=46, createdTime=2020-05-28, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a7519480ec3, moduleTitle=Hepatology：研究发现新的机制或可提高肝细胞癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a7519480ec3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256767, encodeId=23d61256e67a0, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet：羟基氯喹/氯喹治疗COVID-19结果公布：降低生存率！, objectType=article, longId=194624, objectId=1c2a19462414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c2a19462414, replyNumber=0, likeNumber=68, createdTime=2020-05-24, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c2a19462414, moduleTitle=Lancet：羟基氯喹/氯喹治疗COVID-19结果公布：降低生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c2a19462414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256766, encodeId=cad61256e66fd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO 2020：信达生物的抗PD-L1单抗TYVYT（Sintilimab）显着改善了食管鳞状细胞癌患者的总体生存率(ORIENT-2研究), objectType=article, longId=194241, objectId=a91619424150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a91619424150, replyNumber=0, likeNumber=75, createdTime=2020-05-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a91619424150, moduleTitle=ASCO 2020：信达生物的抗PD-L1单抗TYVYT（Sintilimab）显着改善了食管鳞状细胞癌患者的总体生存率(ORIENT-2研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a91619424150)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2020中国肺癌防治高峰论坛在京召开，多方助力提高肺癌5年生存率

2020-09-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

三阴性乳腺癌：令人闻风丧胆的肿瘤！3种新疗法或将提高生存率

2020-09-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA：皮质类固醇可提高COVID-19患者的生存率

2020-09-08

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J INTERN MED：痴呆患者服用钙通道阻滞剂与生存率和缺血性卒中之间的关系

2020-08-31

仁者大医 (审核中...)

前往app查看评论内容

#生存率#

JAMA Oncol：三阴性乳腺癌治疗再添“白金方案”，五年无病生存率达86.5%

2020-08-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

EuroIntervention：肥胖悖论——BMI的适度增加与PCI后患者生存率的改善相关

2020-08-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Oncol ：“最毒”乳腺癌生存率提高！精准辅助治疗“复旦方案”登上《美国医学会杂志-肿瘤学》

2020-08-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet Oncol ：不同治疗和影像检查对癌症生存率影响多大？哈佛团队分析200国11种癌症数据

2020-08-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Hepatology：25-羟维生素D的血清的生物利用度而不是总水平与肝细胞癌的生存率有关

2020-08-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAHA：扩张型心肌病患儿心率升高与生存率的关系

2020-08-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NEJM：结肠癌化疗时间减半不影响患者生存率，还可显著降低副作用！

2020-07-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

GUT: COVID-19病毒对肝硬化患者生存率的影响

2020-07-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Hepatology：丙型肝炎相关肝细胞癌患者使用无干扰素直接作用抗病毒药物可以提高生存率

2020-07-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AACR 2020：PD-L1单抗Tecentriq联合卡铂和依托泊苷，可提高小细胞肺癌SCLC生存率

2020-06-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Thorax：家庭可支配收入与肺癌切除术后的长期生存率

2020-06-23

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO 2020丨遗憾！早期局部治疗未能改善原发IV期乳腺癌女性的总生存率

2020-06-06

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Gut：高收入国家的结肠癌和直肠癌生存率

2020-06-04

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Hepatology：研究发现新的机制或可提高肝细胞癌患者的生存率

2020-05-28

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet：羟基氯喹/氯喹治疗COVID-19结果公布：降低生存率！

2020-05-24

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO 2020：信达生物的抗PD-L1单抗TYVYT（Sintilimab）显着改善了食管鳞状细胞癌患者的总体生存率(ORIENT-2研究)

2020-05-17

科室
- - 订阅+
  - 更多科室
工具
服务